PAMINE Drug Patent Profile
✉ Email this page to a colleague
When do Pamine patents expire, and what generic alternatives are available?
Pamine is a drug marketed by Fougera Pharms and is included in one NDA.
The generic ingredient in PAMINE is methscopolamine bromide. There are seven drug master file entries for this compound. Four suppliers are listed for this compound. Additional details are available on the methscopolamine bromide profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Pamine
A generic version of PAMINE was approved as methscopolamine bromide by BRECKENRIDGE PHARM on December 6th, 2011.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for PAMINE?
- What are the global sales for PAMINE?
- What is Average Wholesale Price for PAMINE?
Summary for PAMINE
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 70 |
| Patent Applications: | 2,424 |
| What excipients (inactive ingredients) are in PAMINE? | PAMINE excipients list |
| DailyMed Link: | PAMINE at DailyMed |
US Patents and Regulatory Information for PAMINE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Fougera Pharms | PAMINE | methscopolamine bromide | TABLET;ORAL | 008848-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Fougera Pharms | PAMINE FORTE | methscopolamine bromide | TABLET;ORAL | 008848-002 | Mar 25, 2003 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
